Citizens Jmp Raises Privia Health Group (NASDAQ:PRVA) Price Target to $31.00

Privia Health Group (NASDAQ:PRVA) had its price objective lifted by equities researchers at Citizens Jmp from $30.00 to $31.00 in a research report issued on Friday,Benzinga reports. The firm currently has a “market outperform” rating on the stock. Citizens Jmp’s price target indicates a potential upside of 29.82% from the company’s current price.

A number of other analysts have also weighed in on PRVA. Weiss Ratings restated a “sell (d+)” rating on shares of Privia Health Group in a research report on Wednesday, October 8th. Citigroup restated an “outperform” rating on shares of Privia Health Group in a research report on Friday, August 29th. Stephens reiterated an “overweight” rating and set a $32.00 price target on shares of Privia Health Group in a report on Wednesday, September 24th. Piper Sandler reduced their price target on shares of Privia Health Group from $36.00 to $35.00 and set an “overweight” rating for the company in a report on Monday, August 11th. Finally, JMP Securities boosted their target price on Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, August 29th. Twelve investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $29.08.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA traded down $0.10 during trading hours on Friday, reaching $23.88. 67,676 shares of the stock were exchanged, compared to its average volume of 841,767. The stock’s fifty day simple moving average is $24.14 and its 200 day simple moving average is $22.76. Privia Health Group has a 52 week low of $18.77 and a 52 week high of $26.51. The firm has a market capitalization of $2.93 billion, a price-to-earnings ratio of 215.97, a P/E/G ratio of 3.41 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 earnings per share for the quarter. The business had revenue of $213.61 million for the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. Research analysts predict that Privia Health Group will post 0.14 EPS for the current fiscal year.

Institutional Trading of Privia Health Group

Several institutional investors have recently made changes to their positions in PRVA. JPMorgan Chase & Co. lifted its position in shares of Privia Health Group by 26.2% during the third quarter. JPMorgan Chase & Co. now owns 148,709 shares of the company’s stock valued at $3,703,000 after purchasing an additional 30,845 shares in the last quarter. State of New Jersey Common Pension Fund D lifted its position in shares of Privia Health Group by 22.3% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 99,722 shares of the company’s stock worth $2,483,000 after buying an additional 18,188 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in shares of Privia Health Group by 9.6% during the 3rd quarter. PNC Financial Services Group Inc. now owns 7,731 shares of the company’s stock worth $193,000 after buying an additional 675 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in shares of Privia Health Group by 25.9% in the 3rd quarter. Public Sector Pension Investment Board now owns 450,010 shares of the company’s stock worth $11,205,000 after buying an additional 92,507 shares during the last quarter. Finally, Illinois Municipal Retirement Fund grew its holdings in shares of Privia Health Group by 1.1% in the third quarter. Illinois Municipal Retirement Fund now owns 55,501 shares of the company’s stock valued at $1,382,000 after acquiring an additional 585 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.